biovail corp defendants agree to settle in shareholder lawsuit biovail corp and other defendants have agreed to settle class action shareholder litigation for about &# million with insurance coverage reducing the amount payable to &# million the lawsuit filed in the u s district court for the southern district of new york alleged that the drug company and certain officers and directors "made material misrepresentations concerning biovails financial results and business by improperly reporting revenue and earnings attributable to sales " and that the misrepresentations inflated the companys share price 
